Cardiovascular Drug Deal: Everest Medicines signed an exclusive Asia-Pacific licensing agreement for Sumecigrel (Vicagrel), covering Southeast Asia, South Korea, Australia, Hong Kong, Macao and Taiwan, with an RMB 20 million upfront plus milestones—aimed at antiplatelet prevention of ACS, ischemic stroke and PAD. Ophthalmology Expansion: Everest also bought rights to develop and commercialize LNZ100 (VIZZ, aceclidine 1.44% eye drops) in Greater China, including Macao—once-daily treatment for presbyopia designed to improve near vision while avoiding myopic shift. Food Safety Alert: Macau’s IAM ordered a local plant to stop production and recall affected boneless chicken feet after Listeria was found in samples, with higher-risk groups urged to stay alert for symptoms. Public Health Support: Macau’s Health Bureau honoured 1,009 residents who reached five blood donations in 2025 ahead of World Blood Donor Day, noting transfusions supported 3,669 patients. Wellness in the City: MGM Macau and MGM Cotai earned WELL Platinum certification for healthier built environments, while a “Wondera Festival” wellness-and-culture event returns at Navy Yard with free zones and workshops ahead of Global Wellness Day. Anti-Smoking Push: Macau lawmakers passed an outline to expand outdoor smoking bans, ban e-cigarettes in public spaces, and allow body-worn cameras for inspectors. Life Expectancy Update: Macau reported average life expectancy hit 83.5 years in 2025 (80.6 men, 86.3 women), citing increased public health spending. Health Industry Links: A Macao government delegation visited Brazil to expand medical and biopharma cooperation, including TCM and pharmaceutical partnerships.